ID: ALA4441630

Max Phase: Preclinical

Molecular Formula: C17H17ClN4O

Molecular Weight: 328.80

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cccc(Cl)c1)c1cncc(N2CC3CC(C2)N3)c1

Standard InChI:  InChI=1S/C17H17ClN4O/c18-12-2-1-3-13(5-12)21-17(23)11-4-16(8-19-7-11)22-9-14-6-15(10-22)20-14/h1-5,7-8,14-15,20H,6,9-10H2,(H,21,23)

Standard InChI Key:  DJSUCHMXQOIATH-UHFFFAOYSA-N

Associated Targets(Human)

Neuronal acetylcholine receptor; alpha3/beta4 2283 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuronal acetylcholine receptor; alpha4/beta2 3972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neuronal acetylcholine receptor; alpha4/beta2 3557 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuronal acetylcholine receptor protein alpha-7 subunit 3047 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.80Molecular Weight (Monoisotopic): 328.1091AlogP: 2.54#Rotatable Bonds: 3
Polar Surface Area: 57.26Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: 2.03CX LogD: 0.32
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.91Np Likeness Score: -1.56

References

1. Murineddu G, Gotti C, Asproni B, Corona P, Martinello K, Plutino S, Fucile S, Temml V, Moretti M, Viani P, Schuster D, Piras S, Deligia F, Pinna GA..  (2019)  Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors.,  180  [PMID:31299587] [10.1016/j.ejmech.2019.06.079]

Source